Investment Hints at Future Healthcare Priorities
According to a report published by StartUp Health, early stage investments have reached close to $4 billion this year.
The finds were invested into 155 deals at seed and Series A in the investment process.
The five leading investment groupings were as follows:
Patient experience ($958 million);
Wellness with ($854 million);
Personalized medicine with ($524 million);
Big Data analytics ($406 million);
Workflow ($328 million).
"Personalised health has become an explosive winner while patient experience maintains strong and steady growth," the report said.
Figures in 2015 confirmed that early stage investments in the first six months were $3.5 billion, with $7 billion the total sum for the year.
While Series A deals garnered more capital, the report said that distribution of investment between seed and series A projects was almost equal.
The report said that this was owing to the fact that seed companies are new businesses and that "companies receiving seed financing are burdened with proving their model works on little capital, while opportunities for Series A funding remain abundant.”
To date in 2016, 450 investors have provided capital to the healthcare sector. Twenty-one organisations have invested in deals.
See Also: Healthcare Reform Pushes Need to Merge, Acquire or Partner
In terms of top deals, they came in as follows:
$500 billion deal for Chinese patient-scheduling app Ping A Good Doctor;
$400 million for wellness and insurance company Oscar;
$220 million for Human Longevity, a big data and diagnostics firm;
$175 million for Flatiron, a big data and personalised medicine company;
$160 million for Clover, a wellness and insurance provider.
The report also indicated that an increasing number of genome-sequencing companies and medical device makers are attracting funding. Health-centric start-ups focusing on consumers aged above 50 are also attracting funding,
Source: HealthcareIT News
Image Credit: Pixabay
Published on : Tue, 12 Jul 2016
Print as PDF
The fully featured ICU ventilator, HAMILTON-MR1, guarantees uncompromised continuous ventilation care from the ICU to the MRI scanner and back. Its reliability and high performance, with advanced lung-protective strategies and patient-adaptive modes,...
The HAMILTON-T1 combines for the first time the functionality of a fully featured intensive care unit ventilator with the compactness and ruggedness required for transport. This is why the HAMILTON-T1 enables you to provide optimal ventilation therapy...
The HAMILTON-C3 ventilator is a modular high-end ventilation solution for all patient groups. Offering a number of unique features, the HAMILTON-C3 is one of the first ventilators featuring the “Ventilation Autopilot” INTELLiVENT-ASV®. The HAMILTON-C3’s...